A series of new 2-substituted 8-methyl-5-(2-pyridinylethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles have been synthesized. Their activity profiles were studied on a broad panel of therapeutic targets including GPC-receptors, ion channels, and neurotransmitter transporters. One of the studied compounds, 2-methyl-3-{2-[8-methyl-5-(2-pyridin-2-ylethyl)-2,3,4,5-tetrahydropyridino[4,3-b]indol-2-yl]ethyl}-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one, was found to be a highly active antagonist of adrenergic α1A, α1B, α1D, and α2A receptors and serotonin 5-HT2A, 5-HT2B, 5-HT2C, and 5-HT7 receptors. The results were considered in terms of structure—activity relationships. It was established that introduction of bulky substituents into the 2-position of the other synthesized 8-methyl-5-(2-pyridinylethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles led to an activity decrease of the corresponding derivatives as compared with that of the 2,8-dimethyl analogs.
Similar content being viewed by others
References
A. V. Ivashchenko, O. D. Mitkin, M. G. Kadieva, S. E. Tkachenko, Usp. Khim., 79, 325–347 (2010).
World Patent WO 2000/037466; Chem. Abstr., 133, 74013 (2000).
N. Khorana, A. Purohit, K. Herrick-Davis, et al., Bioorg. Med. Chem., 11, 717–722 (2003).
A. M. Ismaiel, M. Dukat, D. L. Nelson, et al., Med. Chem. Res., 6, 197–211 (1996).
N. Khorana, C. Smith, K. Herrick-Davis, et al., J. Med. Chem., 46, 3930–3937 (2003).
International Patent WO 1999/012926; Chem. Abstr., 130, 237551 (1999).
M. Abou-Gharbia, U. R. Patel, M. B. Webb, et al., J. Med. Chem., 30, 1818–1823 (1987).
A. V. Ivachtchnko, E. B. Frolov, O. D. Mitkin, et al., Bioorg. Med. Chem. Lett., 20, 78–82 (2010).
A. V. Ivachtchenko, E. B. Frolov, O. D. Mitkin, et al., Bioorg. Med. Chem. Lett., 19, 3183–3187 (2009).
I. Okun, S. Tkachenko, A. Khvat, et al., Curr. Alzheimer Res., 7, 97–112 (2010).
B. L. Roth, D. J. Shefeer, W. K. Kroeze, Nat. Rev. Drug Discovery, 3, 353–360 (2004).
K. Bhandari, V. A. Murti, P. C. Jain, et al., Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem., 17, 246–254 (1979).
C. A. Harbert, J. J. Plattner, W. M. Welch, et al., J. Med. Chem., 23, 635–643 (1980).
A. Malgaroli, D. Milani, J. Meldolesi, et al., J. Cell Biol., 105, 2145–2155 (1987).
R. Y. Tsien, in: Optical Methods in Cell Physiology, P. DeWeer, B. Salzberg (eds.), J. Wiley & Sons, Inc., New York (1986), pp. 327–345.
A. V. Ivashchenko, O. D. Mitkin, M. G. Kadieva, et al., Izv. Vyssh. Uchebn. Zaved., Khim. Khim. Tekhnol., 52, 31–37 (2009).
A. W. M. Simpson, Methods Mol. Biol., 114, 1–359 (1999).
E. Neher, Neuropharmacology, 34, 1423–1442 (1995).
C. Routledge, S. M. Bromidge, S. F. Moss, et al., Br. J. Pharmacol., 130, 1606–1612 (2000).
A. V. Ivashchenko, E. B. Frolov, O. D. Mitkin, et al., Izv. Vyssh. Uchebn. Zaved., Khim. Khim. Tekhnol., 52, 55–60 (2009).
P. Kasila, H. Harney, http://las.perkinelmer.com/content/relatedmaterials/posters/pst_lancecampgasgaicoupledreceptors.pdf .
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 47, No. 1, pp. 13–20, January, 2013.
Rights and permissions
About this article
Cite this article
Ivachtchenko, A.V., Mitkin, O.D., Kysil, V.M. et al. Synthesis and receptor activity of 2-substituted 8-methyl-5-(2-pyridinylethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles. Pharm Chem J 47, 12–19 (2013). https://doi.org/10.1007/s11094-013-0887-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-013-0887-4